Thirty-seven multidrug-resistant and 13 pan-susceptible isolates of Mycobacterium tuberculosis were analysed for the diversity of genotypes associated with known drug-resistance mechanisms. The isolates were obtained from patients attending a university tuberculosis clinic in Monterrey, Mexico. A total of 25 IS6110-RFLP patterns were obtained from the multidrug-resistant tuberculosis (MDR-TB) isolates. Approximately 65 % of the MDR-TB isolates were attributed to secondary resistance. Different drug-susceptibility patterns were seen with the clustered isolates. The percentage of isolates resistant to isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STR) was 100, 97.3, 48.7 and 67.6, respectively. The most common resistance-associated polymorphisms for the four drugs were as follows: INH, Ser315Thr (67.6 %) in katG; RIF, Ser450Leu (41.7 %) in rpoB; EMB, Met306Ile/Val/Leu (66.7 %) in embB; and STR, Lys43Arg (24 %) in rpsL. Drug-resistance-associated mutations were similar to changes occurring in isolates from other areas of the world, but unique, previously unreported, mutations in katG (n = 5), rpoB (n = 1) and rrs (n = 3) were also identified.
Anonymous1998b; Guidelines for surveillance of drug resistance in tuberculosis.WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 2:72–89
ChavesF.,
YangZ. H.,
El HajjH.,
AlonsoM.,
BurmanW. J.,
EisenachK. D.,
DrondaF.,
BatesJ. H.,
CaveM. D.1996; Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol 34:1118–1123
ColeS. T.,
BroschR.,
ParkhillJ. & 39 other authors; 1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544[CrossRef]
HeymB.,
AlzariP. M.,
HonoréN.,
ColeS. T.1995; Missense mutations in the catalase-peroxidase gene, katG , are associated with isoniazid resistance in Mycobacterium tuberculosis
. Mol Microbiol 15:235–245[CrossRef]
JinD. J.,
GrossC. A.1988; Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 202:45–58[CrossRef]
KapurV.,
LiL. L.,
IordanescuS.,
HamrickM. R.,
WangerA.,
KreiswirthB. N.,
MusserJ. M.1994; Characterization by automated DNA sequencing of mutations in the gene ( rpoB ) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 32:1095–1098
MarttilaH. J.,
SoiniH.,
EerolaE.,
VyshnevskayaE.,
VyshnevskiyB. I.,
OttenT. F.,
VasilyefA. V.,
ViljanenM. K.1998; A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St.Petersburg area in Russia. Antimicrob Agents Chemother 42:2443–2445
NairJ.,
RouseD. A.,
BaiG.-H.,
MorrisS. L.1993; The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis
. Mol Microbiol 10:521–527[CrossRef]
National Committee for Clinical Laboratory Standards1995Antimycobacterial Susceptibility Testing for Mycobacterium tuberculosis. Proposed Standard M24-T Villanova, PA: National Committee for Clinical Laboratory Standards;
RaviglioneM. C.,
SniderD. E.Jr,
KochiA.1995; Global epidemiology of tuberculosis.Morbidity and mortality of a worldwide epidemic. JAMA (J Am Med Assoc) 273:220–226[CrossRef]
RinderH.,
DobnerP.,
FeldmannK.,
RifaiM.,
BretzelG.,
Rusch-GerdesS.,
LoscherT.1997; Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M.tuberculosis isolates from Germany and Sierra Leone. Microb Drug Resist 3:195–197[CrossRef]
SreevatsanS.,
PanX.,
StockbauerK. E.,
WilliamsD. L.,
KreiswirthB. N.,
MusserJ. M.1996; Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 40:1024–1026
SreevatsanS.,
PanX.,
StockbauerK. E.,
ConnellN. D.,
KreiswirthB. N.,
WhittamT. S.,
MusserJ. M.1997a; Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 94:9869–9874[CrossRef]
TelentiA.,
HonoreN.,
BernasconiC.,
MarchJ.,
OrtegaA.,
HeymB.,
TakiffH. E.,
ColeS. T.1997a; Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis : a blind study at reference laboratory level. J Clin Microbiol 35:719–723
TelentiA.,
PhilippW. J.,
SreevatsanS.,
BernasconiC.,
StockbauerK. E.,
WielesB.,
MusserJ. M.,
JacobsW. R.Jr1997b; The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3:567–570[CrossRef]
van EmbdenJ. D.,
CaveM. D.,
CrawfordJ. T. & 8 other authors; 1993; Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31:406–409
Viader-SalvadóJ. M.,
Luna-AguirreC. M.,
Reyes-RuizJ. M.,
Valdez-LealR.,
Bosque-MoncayoM. D. L. A. D.,
Tijerina-MenchacaR.,
Guerrero-OlazaránM.2003; Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. Microb Drug Resist 9:33–38[CrossRef]
VictorT. C.,
van RieA.,
JordaanA. M.,
RichardsonM.,
van der SpuyG. D.,
BeyersN.,
van HeldenP. D.,
WarrenR.2001; Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance. J Clin Microbiol 39:4184–4186[CrossRef]
World Health Organization1997Anti-tuberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1994–1997; WHO/TB/97.229 Geneva: WHO Global Tuberculosis Programme;
YangZ. H.,
RendonA.,
FloresA. & 7 other authors; 2001; A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico. Int J Tuberc Lung Dis 5:313–320